Telomir Pharmaceuticals (TELO): Rentabilitas operasi

Logo perusahaan publik Telomir Pharmaceuticals Corp (TELO)

Telomir Pharmaceuticals is diversifying its telomere regulation research, expanding into veterinary medicine and the treatment of fibrosis. The operating profit margin reflects current trends, with the value holding at 0.00. While the business currently relies on scientific grants without stable commercial revenue, the scaling potential is immense due to the future sale of unique anti-aging formulas to millions of consumers.

TELO: Rentabilitas kegiatan operasi Telomir Pharmaceuticals, Inc. 21.02.2024 - 20.11.2026

telomirpharma.com - rincian analitis lan metrik utama (TELO)

Ringkesan analitik perusahaan:Telomir Pharma, TELO
Produk merek Telomir Pharmaceuticals

Investors are assessing fundamental risks through profit generation efficiency, excluding the impact of debt load and taxes. Outsourcing production to CDMO plants optimizes costs for Telomir Pharmaceuticals (TELO), which is reflected in the recorded operating margin as the ratio of operating income to revenue; the growth of this indicator confirms the high profitability of the core business and the resilience of capital to operational disruptions.

Analisis pesaing Telomir Pharmaceuticals

Rentabilitas operasi haleon.com|Rentabilitas operasi KVUE|Rentabilitas operasi Verona Pharma (VRNA)|Jyong Biotech (MENS) - Tingkat bathi adhedhasar bathi operasi|Margin operasi LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Rentabilitas operasi|PRGO - Rentabilitas operasi|Alvotech Corp (ALVO) - Margin dodolan operasi|LQDA: Margin operasi|Rentabilitas dodolan operasi glpg.com (GLPG)|Rentabilitas operasi ANI Pharmaceuticals Inc|MNKD: Tingkat bathi operasi|Margin dodolan operasi AMPH (Amphastar)|PCRX - Rentabilitas dodolan operasi|Margin operasi SPRY (ars-pharma.com)|Tingkat bathi operasi TBPH|Aquestive Therapeutics, Inc. - Margin operasi|scpharmaceuticals.com - Rasio bathi operasi|Tectonic (TECX) - Rentabilitas operasi|Margin dodolan operasi Tonix Pharmaceuticals Inc.|Rentabilitas operasi sxtchina.com|Margin dodolan operasi Eupraxia Pharmaceuticals (EPRX)|Margin operasi BHST|EXOZ - Rentabilitas dodolan operasi|Oramed - Margin dodolan operasi|Entera Bio Ltd. (ENTX) - Rentabilitas dodolan operasi|HYFT - Rentabilitas operasi|ABVC: Rentabilitas operasi|CPIX: Margin operasi|Quantum BioPharma Ltd. - Tingkat bathi operasi|FGEN (FibroGen Corp) - Margin operasi|Margin operasi ranitherapeutics.com|Rentabilitas operasi Synergy CHC Corp. (SNYR)|Rallybio Corp - Rentabilitas dodolan miturut bathi operasi|lexariabioscience.com - Margin dodolan operasi|Margin operasi Pulmatrix Inc PULM|Pheton Holdings - Margin operasi|Margin bathi operasi APM|Lyra Therapeutics, Inc. (LYRA) - Rentabilitas operasi|Rentabilitas dodolan operasi Impact BioMedical, Inc. (IBO)|Rentabilitas operasi TNF Pharma|YCBD: Tingkat bathi operasi|Margin operasi PRFX|CYTO - Rentabilitas dodolan operasi|Rentabilitas operasi Lipella LIPO|Rasio bathi operasi OPTN (OptiNose, Inc.)|PIRS - Rentabilitas operasi|Procaps (PROC) - Margin dodolan operasi|PTPI: Margin operasi|Qilian International (QLI) - Margin operasi|Rentabilitas operasi Acelyrin, Inc.|Margin operasi TFF Pharmaceuticals, Inc.